| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
5,560,000,000 |
| Market
Cap: |
157.79(B) |
| Last
Volume: |
23,526,547 |
Avg
Vol: |
30,558,062 |
| 52
Week Range: |
$25.26 - $40.28 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
| |
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 6.5 |
| Insider 3/6 Months : 7.1 |
|
| Guru Rank Number : 710 |
| Guru Rank Value : 1.7 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Pfizer is a research-based biopharmaceutical company. Co. is engaged in the discovering, developing, manufacturing, marketing, sales and distribution of biopharmaceutical products. Co.'s business includes: internal medicine, which includes cardiovascular metabolic and pain products; oncology, which includes products in biologics, small molecules, immunotherapies, and biosimilars for cancers; hospital, which includes Co.'s portfolio of sterile injectable and anti-infective medicines, as well as Pfizer CentreOne; vaccines, which includes vaccines brands in pneumococcal disease, meningococcal disease, tick-borne encephalitis and COVID-19; inflammation and immunology; and rare disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
3,000 |
3,000 |
5,000 |
| Total Buy Value |
$0 |
$79,401 |
$79,401 |
$156,406 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
18,130 |
| Total Sell Value |
$0 |
$0 |
$0 |
$826,281 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
3 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Young John D |
Group President |
• • – |
2019-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,280 |
367,825 |
|
- |
|
| Hwang Angela |
Group President |
• • – |
2019-11-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
216 |
8,532 |
|
- |
|
| Cangialosi Loretta V |
Sr. Vice President, Controller |
• • – |
2019-11-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
660 |
108,435 |
|
- |
|
| Hwang Angela |
Group President |
• • – |
2019-08-30 |
4 |
A |
$35.55 |
$351,803 |
I/I |
9,896 |
13,079 |
|
- |
|
| Gottlieb Scott |
Director |
• • – |
2019-08-23 |
4 |
B |
$34.72 |
$104,160 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
| Damelio Frank A |
Executive Vice President |
• • – |
2019-07-02 |
4 |
AS |
$44.00 |
$6,753,385 |
D/D |
(153,184) |
337,392 |
|
- |
|
| Mackenzie Alexander R |
Executive Vice President |
• • – |
2019-06-20 |
4 |
AS |
$44.00 |
$1,320,000 |
D/D |
(30,000) |
80,094 |
|
- |
|
| Hwang Angela |
Group President |
• • – |
2019-05-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
240 |
8,748 |
|
- |
|
| Rogers Dawn |
Executive Vice President |
• • – |
2019-04-29 |
4 |
D |
$39.59 |
$168,455 |
D/D |
(4,255) |
10,665 |
|
- |
|
| Mackenzie Alexander R |
Executive Vice President |
• • – |
2019-04-01 |
4 |
AS |
$42.59 |
$642,503 |
D/D |
(15,000) |
110,094 |
|
- |
|
| Johnson Rady A |
Executive Vice President |
• • – |
2019-03-15 |
4 |
S |
$41.13 |
$357,831 |
D/D |
(8,700) |
59,797 |
|
- |
|
| Read Ian C |
Executive Chairman |
• • – |
2019-03-04 |
4 |
AS |
$43.08 |
$2,198,474 |
D/D |
(50,788) |
1,639,280 |
|
- |
|
| Read Ian C |
Executive Chairman |
• • – |
2019-03-04 |
4 |
AS |
$43.00 |
$22,882,702 |
D/D |
(530,078) |
1,109,202 |
|
- |
|
| Susman Sally |
Executive Vice President |
• • – |
2019-03-04 |
4 |
AS |
$42.90 |
$377,444 |
D/D |
(8,725) |
172,094 |
|
- |
|
| Susman Sally |
Executive Vice President |
• • – |
2019-03-04 |
4 |
AS |
$42.89 |
$2,760,698 |
D/D |
(63,998) |
108,096 |
|
- |
|
| Dolsten Mikael |
President R&D |
• • – |
2019-03-04 |
4 |
S |
$43.52 |
$2,136,293 |
D/D |
(49,082) |
289,126 |
|
- |
|
| Rogers Dawn |
Executive Vice President |
• • – |
2019-03-04 |
4 |
S |
$42.98 |
$644,798 |
D/D |
(15,002) |
14,920 |
|
- |
|
| Dolsten Mikael |
President R&D |
• • – |
2019-03-01 |
4 |
S |
$43.56 |
$4,376,852 |
D/D |
(100,471) |
338,208 |
|
- |
|
| Dolsten Mikael |
President R&D |
• • – |
2019-03-01 |
4 |
OE |
$30.59 |
$3,328,057 |
D/D |
106,191 |
438,679 |
|
- |
|
| Fonseca Lidia |
Executive Vice President |
• • – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
47,510 |
47,510 |
|
- |
|
| Cangialosi Loretta V |
Sr. Vice President, Controller |
• • – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,482 |
108,607 |
|
- |
|
| Bourla Albert |
Chief Executive Officer |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$2,197,857 |
D/D |
(51,770) |
280,212 |
|
- |
|
| Bourla Albert |
Chief Executive Officer |
• • – |
2019-02-27 |
4 |
OE |
$32.23 |
$2,073,098 |
D/D |
64,322 |
331,982 |
|
- |
|
| Bourla Albert |
Chief Executive Officer |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
96,183 |
267,660 |
|
- |
|
| Rogers Dawn |
Executive Vice President |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$642,014 |
D/D |
(15,127) |
34,865 |
|
- |
|
1390 Records found
|
|
Page 12 of 56 |
|
|
0.06 (0.21%) 
